Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for the treatment of IBS-D: Identifying the responder
2008-000623-25Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in Diarrhea-predominant irritable bowel syndrome (IBS-D) (2 arms), sponsored by University of Nottingham. Started Sep 2008; status: completed.
02
Drugs
ondansetron
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on 2008-000623-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000623-25.